Fingerprint
Dive into the research topics of 'A phase I study of combination therapy with immunotoxins IgG-HD37- deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically